Biotech · Private company
CoLucid Pharmaceuticals
Track this companyFree. Adds CoLucid Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials6
- Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose AdministrationPHASE1 · COMPLETED · started Apr 20, 2017ClinicalTrials.gov NCT03040362 · fetched Nov 12, 2026
- Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy ParticipantsPHASE1 · COMPLETED · started Mar 21, 2017ClinicalTrials.gov NCT03076970 · fetched Nov 12, 2026
- Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic FunctionPHASE1 · COMPLETED · started Mar 14, 2017ClinicalTrials.gov NCT03040479 · fetched Nov 12, 2026
- Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of MigrainePHASE3 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02605174 · fetched Nov 12, 2026
- An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of MigrainePHASE3 · COMPLETED · started Oct 7, 2015ClinicalTrials.gov NCT02565186 · fetched Nov 12, 2026
- Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:PHASE3 · COMPLETED · started Apr 1, 2015ClinicalTrials.gov NCT02439320 · fetched Nov 12, 2026